Extensive experience in drug development and medical expertise, Carlos plays a crucial role in driving the company’s clinical development strategies and ensuring the safety and efficacy of their pharmaceutical products. His leadership and deep understanding of the industry contributes to the advancement of innovative therapies and the improvement of patient outcomes. Carlos Batthyany’s dual roles as CMO of Eolo Pharma and Head of the Institut Pasteur de Montevideo make him a highly respected and influential figure in the scientific and pharmaceutical communities.